Phylogenetic Analysis of Enterohemorrhagic Escherichia coli O157, Germany, 1987–2008 by Jenke, Christian et al.
Multilocus variable number tandem repeat analysis 
(MLVA) is a subtyping technique for characterizing human 
pathogenic bacteria such as enterohemorrhagic Escheri-
chia coli (EHEC) O157. We determined the phylogeny of 
202 epidemiologically unrelated EHEC O157:H7/H– clini-
cal isolates through 8 MLVA loci obtained in Germany dur-
ing 1987–2008. Biodiversity in the loci ranged from 0.66 
to 0.90. Four of 8 loci showed null alleles and a frequency 
<44.1%. These loci were distributed among 48.5% of all 
strains. Overall, 141 MLVA proﬁ  les were identiﬁ  ed. Phylo-
genetic analysis assigned 67.3% of the strains to 19 MLVA 
clusters. Speciﬁ  c MLVA proﬁ  les with an evolutionary persis-
tence were identiﬁ  ed, particularly within sorbitol-fermenting 
EHEC O157:H–.These pathogens belonged to the same 
MLVA cluster. Our ﬁ  ndings indicate successful persistence 
of this clone.
E
nterohemorrhagic Escherichia coli (EHEC) O157:H7 
infections have substantial medical, public health, and 
economic effects (1,2). Most symptomatically infected pa-
tients have painful bloody diarrhea (2,3). Hemolytic uremic 
syndrome (HUS) develops in ≈15% of infected children ≈1 
week after the ﬁ  rst loose stool. HUS is a thrombotic mi-
croangiopathy and consists of nonimmune hemolytic ane-
mia, thrombocytopenia, and renal failure (1). Currently, 
HUS is the main cause of acute renal failure in children (4). 
In Germany, E. coli O157:H7, which is the most frequent 
EHEC serotype implicated in HUS, is not the only relevant 
EHEC O157 involved. Sorbitol-fermenting (SF) E.  coli 
O157:H– (nonmotile) strains cause ≈20% of all cases of 
HUS (5). Unlike E. coli O157:H7, organisms within this 
clone can ferment sorbitol after overnight incubation on sor-
bitol MacConkey agar. Although EHEC O157:H7 causes a 
zoonotic disease mainly associated with cattle, efforts to 
determine the animal reservoir of SF EHEC O157:H– have 
been unsuccessful (5).
To identify reservoirs of EHEC O157:H7 infections 
and of other foodborne pathogens and to elucidate the 
molecular epidemiology of these pathogens in the United 
States, PulseNet was established in 1996 (6). This US na-
tional molecular subtyping network for foodborne disease 
surveillance facilitates subtyping of bacterial foodborne 
pathogens for epidemiologic purposes. This network is 
based on characterization of whole bacterial genomes by 
using macrorestriction digestion patterns that are separated 
by pulsed-ﬁ  eld gel electrophoresis (PFGE), a technique that 
has emerged as a common standard for subtyping EHEC 
O157 isolates (6). Despite its high discriminatory power, 
PFGE can be problematic because it requires great efforts 
to ensure intralaboratory and interlaboratory reproducibil-
ity (7–10). Furthermore, its application is labor-intensive 
and difﬁ  cult to automate. Thus, this technique can be bi-
ased by subjective interpretation of band patterns (7,8). In 
addition, band patterns can be altered by the presence of 
mobile genetic elements.
To overcome these drawbacks, other molecular meth-
ods were developed, among them multilocus variable num-
ber tandem repeat (VNTR) analysis (MLVA). MLVA is 
based on the characterization of different VNTR regions 
throughout the bacterial genome. Repeat regions are am-
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pliﬁ  ed by using PCRs, and resulting fragments are sized 
to determine the number of repeats. The combination of 
numbers of repeats of different VNTR loci results in an 
allelic proﬁ  le known as the typing result. First developed 
in 1995 for Mycobacterium tuberculosis (11), MLVA is 
now a common typing method for an increasing number 
of pathogens (12,13). For EHEC O157, different MLVA 
schemes with some overlaps of VNTR regions have been 
published and have demonstrated a capability to detect out-
breaks and differentiate closely related EHEC O157 iso-
lates not discriminated by PFGE (8,14,15). These ﬁ  ndings 
qualify MLVA as the second-generation subtyping method 
for PulseNet (8).
In addition to its use in infectious disease surveillance, 
MLVA also can be used to study phylogeny of pathogens, 
especially recently evolved clonal pathogens such as M. 
tuberculosis (16,17) or Bacillus anthracis (18). However, 
because of limited diversity in their housekeeping genes, 
which are the genomic targets for phylogenetic investiga-
tions based on multilocus sequence typing (MLST), the 
common technique for phylogenetic studies (19,20), cer-
tain monomorphic organisms could not be sufﬁ  ciently dif-
ferentiated by MLST (16,18). Similarly, EHEC O157 lacks 
diversity in its housekeeping genes (21,22), which hampers 
phylogenetic analysis of EHEC O157 by MLST.
We investigated the phylogeny of EHEC O157:H7 and 
SF EHEC O157:H– strains isolated during 1987–2008 in 
Germany by applying the current PulseNet MLVA proto-
col for E. coli O157 (23). The purpose of our study was to 
gain a deeper insight into the evolution and spread of this 
pathogen since 1987, when the ﬁ  rst cases of EHEC O157 
infections were detected (24,25).
Materials and Methods
Clinical Isolates
Up to 17 epidemiologically unrelated EHEC O157:
H7/H– isolates per year obtained during 1987–2008 were 
randomly selected from the strain collection of the Insti-
tute of Hygiene and the National Consulting Laboratory 
on HUS, University Hospital Münster, Germany. All 202 
O157 strains (61 of which were SF EHEC O157:H–) were 
isolated from humans, including patients with HUS (145), 
bloody diarrhea (12), or diarrhea without visible blood 
(40), and asymptomatic carriers (5) during epidemiologic 
investigations. Isolates were obtained from areas through-
out Germany. Procedures used for detecting and isolating 
EHEC O157 from stool samples were described (26,27). 
Isolates were conﬁ  rmed as E. coli by the API 20 E test (bio-
Mérieux, Marcy l’Etoile, France) and serotyped by using 
antisera against E. coli O antigens 1–181 and H antigens 
1–56 (28). Subtyping of ﬂ  iC genes in nonmotile isolates 
by using HhaI restriction fragment length polymorphism of 
amplicons obtained with primers FSa1 and rFSa1 (29,30) 
conﬁ  rmed the presence of ﬂ  iCH7 in all isolates. EHEC 
O157:H7 strain EDL933 (31,32) was used as a reference 
strain in all analyses.
MLVA of EHEC O157
Strains were grown overnight on Columbia blood agar 
(Heipha; Eppelheim, Germany) at 37°C. A loop of a fresh 
culture was suspended in 100 μL of Chelex-100 solution 
(Bio-Rad, Hercules, CA, USA) and vortexed brieﬂ  y. Af-
ter boiling and thorough mixing, samples were centrifuged 
and DNA-containing supernatants were stored at –20°C 
until use. To calibrate sequencer-speciﬁ   c variation of 
fragment length, the exact number of repeats of reference 
strain O157:H7 EDL933 was initially determined in silico 
on the basis of its genome sequence (reference sequences 
NC_002655 [chromosome] and NC_007414 [plasmid]; 
National Center for Biotechnology Information [NCBI], 
Bethesda, MD, USA) by using Tandem Repeats Finder 
software (33). Subsequently, the length of the in silico–de-
termined repeats was subtracted from the fragment length 
of each respective VNTR locus generated in 8 independent 
capillary electrophoresis runs of strain EDL933 to deter-
mine the offset (primer plus VNTR-ﬂ  anking regions). This 
locus-speciﬁ  c offset was then used to calculate the cor-
rect number of repeats of unknown isolates. Fragments for 
MLVA typing were generated in 2 multiplex PCRs com-
prising either VNTR loci 3, 9, 25, and 34 (multiplex 1) or 
VNTR loci 17, 19, 36, and 37 (multiplex 2) (online Ap-
pendix Table, www.cdc.gov/EID/content/16/4/610-appT.
htm), according to the current PulseNet MLVA protocol 
for E. coli O157 (23). 
PCR ampliﬁ  cation was performed in a reaction mixture 
of 10 μL containing 5 μL of Type-it Multiplex Master Mix 
(QIAGEN, Hilden, Germany), ≈30 ng of DNA template, 
and VNTR-speciﬁ  c primers for each of the 4 VNTR loci. 
Concentration, primer sequences, and respective dyes used 
are shown in the online Appendix Table. PCRs were per-
formed and prepared for subsequent analysis on sequencers 
in accordance with the manufacturer’s instructions (online 
Appendix Table). PCR products were diluted 1:10 with wa-
ter puriﬁ  ed by high performance liquid chromatography, 
and 1.0 μL of diluted DNA was mixed with 13.7 μL of 
HiDi formamide (Applied Biosystems, Foster City, CA, 
USA) and 0.3 μL of GeneScan-600 LIZ Size Standard 
(Applied Biosystems) as internal lane size standard. Before 
fragment sizing in the ABI Prism 3130xl Genetic Analyzer 
System (Applied Biosystems), samples were incubated for 
5 min at 95°C and immediately frozen at –20°C for >3 min 
to denature the DNA.
If a VNTR locus was not detected during fragment 
analysis, reactions were repeated by using singleplex re-
actions with minor modiﬁ  cations to amplify the speciﬁ  c 
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locus. In that particular instance, the primer concentra-
tion was increased to 0.2 μmol/L, annealing temperatures 
were reduced to 55°C, and the extension time was tripled 
to amplify larger fragments because of possible insertion 
sequence element transposition or other genetic events. 
Subsequently, fragments were characterized by using stan-
dard agarose gel electrophoresis. If the fragment was larger 
than the usual range of fragment sizes of the corresponding 
VNTR, the PCR product was sequenced.
Data Analysis
After fragment analysis, corresponding peak data 
were examined by using GeneMapper 4.0 software (Ap-
plied Biosystems) to calculate the repeat number for each 
VNTR locus on the basis of fragment length. Partial re-
peats were rounded to the closest repeat number in ac-
cordance with the current Centers for Disease Control 
and Prevention (CDC) (Atlanta, GA, USA) MLVA O157 
protocol (23). If >1 amplicon for a speciﬁ  c VNTR locus 
was detected and the size difference matched >1 repeat 
lengths (so-called stutter peaks), the one with the high-
est ﬂ  uorescence level was used to calculate the repeat 
number. A null allele was assigned if either no amplicon 
was detected or agarose gel electrophoresis data showed 
an amplicon of a size that was beyond the usual range of 
fragment size of the speciﬁ  c VNTR locus. Corresponding 
alleles were designated as –2. In the hypothetical situa-
tion in which an amplicon without the repeat region was 
detected, it was designated as –1 (8). Null alleles were 
also included in the overall number of alleles in a speciﬁ  c 
VNTR locus.
Index of diversity (ID) (34) and typeability were cal-
culated by using EpiCompare 1.0 software (Ridom GmbH, 
Würzburg, Germany). A minimum spanning tree (MST) 
was generated by using SeqSphere software 0.9 β (Ridom 
GmbH). All MLVA proﬁ  les that differed at <2 alleles were 
grouped as an MLVA cluster. To determine the cluster-de-
ﬁ  ning proﬁ  le of clusters containing >2 MLVA proﬁ  les, the 
MST priority rule (that the proﬁ  le with the highest number 
of single locus variants is chosen) was applied.
Signiﬁ  cance of associations of MLVA proﬁ  les or clus-
ters comprising >4 strains with clinical outcome (HUS vs. 
non-HUS) were calculated by using a χ2 test with Yates 
correction (EpiInfo 6 software; CDC) when appropriate. p 
values <0.05 were considered signiﬁ  cant.
Results
EHEC O157 Strains and VNTR Loci Characterization
The 202 EHEC O157 strains showed 141 MLVA pro-
ﬁ   les. Of these proﬁ   les, MLVA proﬁ  le  4/8/-2/2/3/9/-2/5 
was the most common and was present in 30 isolates. In 
contrast, 122 proﬁ  les were detected only once. Detailed 
characteristics of the different VNTR loci identiﬁ  ed in this 
study are shown in Table 1. The number of alleles for the 
VNTRs ranged from 6 (VNTR-25) to 22 (VNTR-3). Calcu-
lation of the ID resulted in values from 0.66 (VNTR-34) to 
0.9 (VNTR-9). Half of the VNTR loci (VNTR-3, VNTR-9, 
VNTR-36, and VNTR-37) showed null alleles with differ-
ent frequencies ranging from 2.0% (VNTR-3 and VNTR-
37) to 44.1% (VNTR-36).
To determine whether ampliﬁ  cation failure caused by 
mutations in primer-binding regions or by complete dele-
tions of the VNTR region were the reason for these null 
alleles or the insertion of fragments such as mobile genetic 
elements resulted in larger (and therefore by capillary elec-
trophoresis) undetectable fragments, the respective frag-
ments were analyzed by using standard gel electrophoresis. 
In some cases, large fragments (>1.3 kb) were detected. 
Sequence analysis and an NCBI nucleotide BLAST search 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) of randomly se-
lected samples indicated the presence of insertion sequence 
elements of the IS3 family. The typeability of different 
VNTR loci ranged from 55.9% to 100% (Table 1). Null 
alleles were present in 48.5% of the strains (98/202). The 
overall ID of all MLVA proﬁ  les was 0.98.
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Table 1. VNTR characteristics of enterohemorrhagic Escherichia coli, Germany, 1987–2008* 
VNTR
locus 
Alternative
name† 
Repeat
length, bp 
Inside ORF 
(no.)‡ 
No. repeats  No.
alleles§ 
Null
alleles 
Null allele 
frequency, %  ID
Typeability, 
%¶  Minimum Maximum 
3 Vhec3, TR5  6 + (Z0268)  3 23 22 + 2.0 0.86 98.0
34 Vhec2, TR6  18 + (Z5865)  4 12 8 – – 0.66 100.0 
9 Vhec4, TR1  6 + (Z3935/Z3936) 6 23 15 + 31.7 0.90 68.3
25 TR4 6 – 2 15 6 – – 0.74 100.0 
17 TR3 6 +  (Z5935)  2 19 10 – – 0.80 100.0 
19 TR7 6 +  (Z3274)  3 11 9 – – 0.76 100.0 
36# Vhec7 7 – 3 15 13 + 44.1 0.87 55.9
37# – 6 + (L7083)  3 17 11 + 2.0 0.82 98.0
*VNTR, variable number tandem repeat; ORF, open reading frame; ID, index of diversity without null alleles.  
†Vhec loci as explained by Lindstedt et al. (15). TR loci are from Noller et al. (14).
‡Number is based on current EDL933 genome data. ORF encoding VNTR loci encoded either hypothetical proteins or proteins with unknown function. 
§Including null alleles. 
¶Typeability determines the proportion of all alleles without null alleles. 
#Located on plasmid pO157 of reference strain EDL933. Phylogenetic Analysis of Enterohemorrhagic E. coli
MLVA Clustering and Phylogeny
Comparison of MLVA proﬁ  les assembled 136 of the 
202 strains (67.3%) into clusters sharing >6 of the 8 VNTR 
loci. This grouping resulted in 19 MLVA clusters consist-
ing of 2–61 isolates comprising 81 MLVA proﬁ  les. The re-
maining 66 strains (32.7%), which had 60 MLVA proﬁ  les, 
could not be associated with any cluster (Table 2). Strains 
within clusters consisting of >4 MLVA proﬁ  les were iso-
lated over a period >7 years. The 61 strains of cluster 1 
were isolated during 1988–2008. Among these strains, the 
cluster-deﬁ  ning MLVA proﬁ  le 4/8/-2/2/3/9/-2/5 was the 
most common proﬁ  le. It included 30 (14.9%) of 202 strains 
isolated during 1988–2008. The proﬁ  le of the same clus-
ter (cluster 1) with the second highest number of strains 
differed only in VNTR-37 with an additional repeat and 
included 5.0% of the strains (10/202). The corresponding 
strains were isolated during 1995–2008 (Table 2, Figure).
All 61 strains in cluster 1 were SF EHEC O157:H–. 
The remaining 141 strains did not ferment sorbitol (Table 
2, Figure). The phylogenetic relationship of 202 EHEC 
O157 strains based on the 141 MLVA proﬁ  les is shown in 
an MST in the Figure. The reference strain EDL933, which 
is also included in the MST, shares its MLVA proﬁ  le with 4 
isolates from Germany obtained during 2007–2008.
Association of MLVA Proﬁ  les with HUS
To determine whether there was an association be-
tween MLVA proﬁ  les or clusters and the ability of these 
strains to cause HUS, we performed a signiﬁ  cance test. The 
2 most common MLVA proﬁ  les were signiﬁ  cantly associ-
ated with HUS (p = 0.023). Testing for speciﬁ  c clusters 
resulted in a signiﬁ  cant association of HUS with cluster 1 
(p = 0.009) (Figure).
Discussion
Using 8 VNTR loci of the current PulseNet MLVA 
O157 protocol (23), we analyzed a large collection of 202 
EHEC O157:H7/H– strains isolated over >2 decades in 
Germany to determine their molecular epidemiology. Of 
the 141 MLVA proﬁ  les detected, 81 were clustered into 
19 groups of related proﬁ  les that differed at >2 loci. The 
remaining 60 proﬁ  les were not clustered. Our data dem-
onstrate a great diversity of EHEC O157:H7 associated 
with human diseases in Germany over the past 2 decades. 
The wide distribution of strains within the MST based 
on MLVA typing reﬂ  ects frequent occurrence of genetic 
events outside the EHEC O157 core genome (Table 2, Fig-
ure). The 19 MLVA clusters included 67.3% (136/202) of 
the analyzed strains. Further analysis of the clusters includ-
ing >4 MLVA proﬁ  les did not show any speciﬁ  c clustering 
of strains in time. Most of the larger clusters (clusters 1, 2, 
4, 5, and 6; Table 2) contained strains widespread in the 
period of 10–20 years. Only cluster 3 is deﬁ  ned by proﬁ  les 
starting from 2001, which indicates a later appearance than 
clusters 1, 2, 4, 5, and 6 (Table 2).
The 2 most frequently identiﬁ  ed MLVA proﬁ  les are 
parts of cluster 1, which indicates a consensus proﬁ  le 
among SF EHEC O157:H– isolates over time within this 
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Table 2. MLVA cluster profile of enterohemorrhagic Escherichia coli O157, Germany, 1987–2008* 
MLVA cluster 
Cluster-defining MLVA 
profile
No. strains  
(% sorbitol-fermenting)  No. MLVA profiles  Years of strain isolation 
1 4/8/-2/2/3/9/-2/5  61 (100)  16 1988, 1989, 1993, 1995–2008 
2 7/7/13/4/5/7/-2/7  11 (0)  7 1996–1998, 2000, 2002, 2005, 2006 
3 11/8/10/3/5/6/8/3  9 (0)  8 2001, 2004, 2005, 2007, 2008 
4 18/7/8/3/5/7/-2/7  8 (0)  8 1996–1999, 2001, 2005, 2006 
5 5/7/13/5/6/6/6/6  7 (0)  5 1991, 1999, 2007 
6 12/7/16/3/5/6/5/7  5 (0)  5 1990, 1992, 1999, 2001, 2004 
7 18/7/10/4/4/9/4/9  5 (0)  4 1996, 1998, 2001–2003  
8 9/7/9/4/6/7/9/8  3 (0)  3 2007, 2008 
9 13/7/11/4/4/8/4/8  3 (0)  3 1992, 1993, 2002 
10 6/6/16/3/6/6/6/6  3 (0)  3 2005, 2006 
11 11/9/10/5/7/6/11/7  3 (0)  3 1996, 2000, 2007 
12 8/10/13/6/7/7/5/6 3 (0)  2 2002 
13 9/7/13/3/6/6/10/7  3 (0)  2 1997, 2002 
14 NA 2 (0) 2 2000 
15 NA 2 (0)  2 1998, 2000 
16 NA 2 (0) 2 1991 
17 NA 2 (0)  2 1995, 1997 
18 NA 2 (0)  2 1998, 2000 
19 NA 2 (0)  2 2001, 2003 
Singletons – 66 (0)  60 All years except 1990, 1995, and 2004 
*MLVA, multilocus variable number tandem repeat analysis; NA, not applicable because cluster comprises <3 strains. Singletons, MLVA profiles that are 
not included in a certain cluster. MLVA profiles are defined by repeat numbers after the following variable number tandem repeat (VNTR) locus order: 
3/34/9/25/17/19/36/37 with EDL933 as standard with the following MLVA profile: 9/10/11/5/6/6/8/7 (based on genome sequence analysis). Strains 
belonged to 1 cluster if they differed at <2 VNTR loci. RESEARCH
cluster. The corresponding strains include strain 493/89, 
which was isolated during the ﬁ  rst documented outbreak 
caused by SF EHEC O157:H– (25). All other isolates that 
exhibited the 2 most common MLVA proﬁ  les also ferment-
ed sorbitol, which identiﬁ  ed strain 493/89 as a prototype of 
these strains. This ﬁ  nding corroborates the assumption of 
an epidemic bacterial population structure within a back-
ground population comprising a network between differ-
ent genotypes, and that superimposed strains emerge from 
highly adaptive, ancestral genotypes and may be persistent 
for decades (35). Nodes from cluster 1, which represent 
the 2 most prevalent MLVA proﬁ  les, include strains from 
1988–2008 and 1995–2008. This ﬁ  nding indicates a per-
sistence of these successful clones, which supports this hy-
pothesis. Moreover, evolutionary success and uniqueness 
of this SF clone was recently supported by whole genome 
single nucleotide polymorphism analysis, in which distinct 
branching of these clones was determined during evolution 
of the O157 serotype (22).
Statistical analysis demonstrated that the 2 most com-
mon proﬁ  les and the entire cluster 1 are associated with 
HUS, which indicates that speciﬁ  c MLVA proﬁ  les are as-
sociated with severe disease. Cluster 1 comprised 61 of 
the strains and was distributed over more than a decade. 
Although not statistically signiﬁ  cant, 10 of 11 isolates in 
cluster 2 were also associated with HUS. Despite these 
similarities, they exhibited different MLVA proﬁ  les (Table 
2; Figure). Extensive heterogeneity of EHEC O157:H7, in 
contrast to conservation of SF EHEC O157:H–, could be 
related to observed differences in the nature of the reser-
voirs and vehicles for transmission. In addition, the epide-
miology of SF EHEC O157:H– infections differs markedly 
because these infections occur predominantly during cold 
(winter) months and in children <3 years of age (5). More-
over, although EHEC O157:H7 infections have zoonotic 
origins, SF EHEC O157:H– are rarely found in animals 
(36). Humans are plausibly the main reservoirs, as is the 
case with classical enteropathogenic E. coli and enteroin-
vasive E. coli. This relatively stable niche may lead to the 
conserved genome structure and high pathogenicity for the 
host (37).
Four strains isolated in 2007 and 2008 exhibited the 
same MLVA proﬁ  le as the reference strain EDL933 iso-
lated in 1982 in the United States (38) (Table 2, Figure). 
Among the 3,200 entries in the CDC MLVA database, the 
EDL933 MLVA proﬁ  le was detected only during an out-
break in 1982 (E. Hyytiä-Trees, pers. comm.). There are 
2 possible explanations for this phenomenon. This ﬁ  nd-
ing is coincidental because of genetic changes in the O157 
genome or EDL933 shares a common MLVA proﬁ  le with 
other strains. The presence of such common proﬁ  les is 
known, especially in foodborne pathogens and other mono-
morphic species (39) and frequently seen by using other 
typing techniques, such as PFGE.
Analysis of the number of alleles of different VNTRs 
produced results similar to those of a previous study (8). 
Whereas the ID was high (0.74–0.90; Table 1) in VNTR 
loci consisting of 6–7-bp repeats (all VNTR loci except 
VNTR-34), the ID was low (0.66) for the 18-bp repeat 
(VNTR-34). Whether a VNTR locus is located within 
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Figure. Minimum spanning tree based on 
multilocus variable number tandem repeat 
analysis (MLVA) allelic proﬁ  les,  showing 
the phylogenetic relationship between 202 
epidemiologically unrelated enterohemorrhagic 
Escherichia coli (EHEC) O157:H7/H– strains, 
Germany, 1987–2008. Each node represents 
a unique MLVA proﬁ   le. Size of the nodes is 
proportional to the number of isolates per MLVA 
proﬁ  le. Small numbers and speciﬁ  c dashed lines 
between nodes represent distance between the 
nodes, i.e., number of different alleles. Clusters 
are indicated by numbers according to their 
size (Table 2) and are highlighted in gray. All 
strains within the enclosed area are sorbitol-
fermenting EHEC O157:H–. The arrangement of 
colors within each node reﬂ  ects the proportion 
of strains isolated from different years per node 
and corresponding MLVA proﬁ  le. Arrow indicates 
reference strain E. coli O157:H7 EDL933.Phylogenetic Analysis of Enterohemorrhagic E. coli
an open reading frame did not inﬂ  uence the ID (Table 
1). However, the frequency of null alleles differed mark-
edly. A total of 98 (48.5%) of 202 strains exhibited null 
alleles in 4 of the 8 VNTR loci. Especially in VNTR-9 and 
VNTR-36, the frequency of null alleles was high (31.7% 
and 44.1%). Although null alleles were reported in other 
MLVA O157 studies (8,40), this high frequency of null 
alleles determined in our study might indicate a speciﬁ  c 
feature of EHEC O157 strains from central Europe or Ger-
many. An explanation for the frequent occurrence might 
be that VNTR-36 and VNTR-9 are located in noncoding 
or hypothetical protein encoding regions of the EHEC ge-
nome (Table 1). Nevertheless, all strains had a high ID re-
garding the complete MLVA proﬁ  le.
Our study had some limitations. Because of the lim-
ited number of isolates obtained during 1987–1995, clus-
tering might be biased and a more year-speciﬁ  c clustering 
might be observable. However, cluster 1 represents 30.2% 
(61/202) of strains widespread during 1988–2008, which 
contradicts this thesis, and infers a certain genetic stability 
of such clusters over time. In contrast to phylogenetic stud-
ies based on whole genome sequencing data (22), we report 
a phylogeny based on 8 genetic loci that might be biased by 
larger recombinational events. However, all VNTR loci are 
>50 kb from the rfb-gnd segment, which was determined to 
be the only genomic region in EHEC O157 with a higher 
mutation rate (22).
Strains (66/202, 32.7%) that were not classiﬁ  able into 
any MLVA cluster complement the assumption of the high-
ly dynamic EHEC O157 genome. This ﬁ  nding likely indi-
cates that genetic changes in E. coli lead to adaptation to a 
host-speciﬁ  c environment (in this case human), especially 
during pathogenesis and host-speciﬁ  c immune responses.
Applying MLVA to this highly diverse strain collec-
tion resulted in new insights into the phylogeny of EHEC 
O157 in Germany since their ﬁ  rst description in 1987. In 
addition to its already demonstrated ability to differenti-
ate outbreak and sporadic case strains, MLVA of O157 
emerged as a major typing tool that can further characterize 
EHEC O157 subpopulations and associated strains. This 
tool can be used for studying phylogeny coherences and 
identifying successful clones.
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